Cover Image

Stevens‐Johnson syndrome/toxic epidermal necrolysis predictive models are not effective when applied by non‐dermatologists: A single‐institution prospective study

Saved in:

Bibliographic Details
Main Authors:	Hunter J. Pyle (Author), Arturo R. Dominguez (Author), Melissa M. Mauskar (Author), Cristina Thomas (Author)
Format:	Book
Published:	Wiley, 2023-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis): Historical considerations
by: Jean-Claude Roujeau
Published: (2013)

Stevens-Johnson syndrome and toxic epidermal necrolysis in children
by: Sudip Das, et al.
Published: (2018)

Update on pathobiology in Stevens-Johnson syndrome and toxic epidermal necrolysis
by: Shih-Chi Su, et al.
Published: (2013)

Steven-Johnson Syndrome/ Toxic Epidermal Necrolysis Overlap Complications
by: Novita Ifamela, et al.
Published: (2024)

DRUG-INDUCED STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS
by: Dalia Dop, et al.
Published: (2016)

A Retrospective Study: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
by: Yuli Wahyu Rahmawati, et al.
Published: (2016)

Study of ocular manifestations of Stevens-Johnson syndrome/toxic epidermal necrolysis
by: Arundha Abrol, et al.
Published: (2020)

Epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in Southeast Asia
by: Haur Yueh Lee, et al.
Published: (2013)

Current Pharmacogenetic Perspective on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
by: Lin Cheng, et al.
Published: (2021)

Cyclosporine in Stevens-Johnson syndrome and toxic epidermal necrolysis: Current scenario
by: Keshavmurthy A Adya
Published: (2018)

Management of stevens-johnson syndrome-toxic epidermal necrolysis: Looking beyond guidelines!
by: Rajesh Kumar, et al.
Published: (2018)

French referral center management of Stevens-Johnson syndrome/toxic epidermal necrolysis
by: Laurence Valeyrie-Allanore, et al.
Published: (2013)

Performance of the SCORTEN in Taiwanese patients with Stevens-Johnson syndrome and toxic epidermal necrolysis
by: Yu-Ling Ho, et al.
Published: (2010)

Absence of Epidermal Antibodies in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Patients but Beware of Single Positive Results
by: Gilles F. H. Diercks, et al.
Published: (2024)

Stevens-Johnson syndrome and toxic epidermal necrolysis: A fresh look at an old foe
by: Sowmya Kaimal, et al.
Published: (2023)

Stevens-Johnson syndrome and toxic epidermal necrolysis in pregnant patients: A systematic review
by: Ajay N. Sharma, BS, et al.
Published: (2020)

Genitourinary management and follow-up for patients with Stevens-Johnson syndrome/toxic epidermal necrolysis
by: Gina T. Baaklini, et al.
Published: (2023)

A retrospective analysis of nursing patients with Stevens-Johnson syndrome or toxic epidermal necrolysis
by: HE Xueyu, et al.
Published: (2024)

Carbamazepine Induced Stevens-Johnson Syndrome That Developed into Toxic Epidermal Necrolysis: Review of the Literature
by: Yousef S. Abuzneid, et al.
Published: (2022)

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Analysis of the Russian Database of Spontaneous Reports
by: Sergey Zyryanov, et al.
Published: (2024)

Pemphigus vulgaris mimicking Steven-Johnson syndrome/toxic epidermal necrolysis: report of an unusual case
by: Latifah Albrahim, et al.
Published: (2023)

Clinicoetiological study of Stevens-Johnson syndrome and toxic epidermal necrolysis spectrum and the correlation of SCORTEN with prognosis
by: Amuthavalli Kanagarajan, et al.
Published: (2023)

Gambaran Klinis Steven Johnson Syndrome dan Toxic Epidermal Necrolysis pada Pasien Anak
by: Annisa Fitriana, et al.
Published: (2018)

Stevens-Johnson syndrome and toxic epidermal necrolysis: 11-year demographic clinical and prognostic characteristics
by: Ayda Acar, et al.
Published: (2022)

Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiological and clinical outcomes analysis in public hospitals
by: Luana Bernardes Arantes, et al.
Published: (2017)

The Profiles of Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) Patients in Tertiary Hospital
by: William Andrew Isaac, et al.
Published: (2021)

Ocular and Mucocutaneous Sequelae among Survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Togo
by: Bayaki Saka, et al.
Published: (2019)

A meta-analysis of cyclosporine treatment for Stevens–Johnson syndrome/toxic epidermal necrolysis
by: Ng QX, et al.
Published: (2018)

Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis over a period of 10 years
by: Abarna Devi Sanmarkan, et al.
Published: (2011)

A pediatric case of Stevens-Johnson syndrome/toxic epidermal necrolysis with rapid response to intravenous cyclosporine
by: Ali Alajmi, MD, et al.
Published: (2020)

Efficacy of cyclosporine for the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: Systemic review and meta-analysis
by: Yu-Tsung Chen, et al.
Published: (2017)

Stevens-Johnson syndrome/toxic epidermal necrolysis overlap triggered by ethosuximide: a rare pediatric report
by: Sandra Soares-Cardoso, et al.
Published: (2023)

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis, A Review of Pathogenesis, Clinical Features, Diagnosis and Treatment
by: Martyna Rozenbajgier, et al.
Published: (2022)

CYP2C19*2 status in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis
by: Laska AJ, et al.
Published: (2017)

Stevens-Johnson syndrome and toxic epidermal necrolysis in an academic hospital setting: a 5-year retrospective study
by: Ewa Stocka-Łabno, et al.
Published: (2016)

Combination of cyclosporine A and methylprednisolone to treat pediatric Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome
by: Shinta Trilaksmi Dewi, et al.
Published: (2023)

Role of oxidative and nitrosative stress in pathophysiology of toxic epidermal necrolysis and Stevens Johnson syndrome-A pilot study
by: Dincy Peter, et al.
Published: (2015)

Acute generalized exanthematous pustulosis simulating Stevens-Johnson syndrome/toxic epidermal necrolysis associated with the use of vismodegib
by: Oscar M. Moreno-Arrones, MD, et al.
Published: (2018)

Epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States and factors predictive of outcomeCapsule Summary
by: Paul Wasuwanich, BSc, et al.
Published: (2023)

Case Report: Suspected Case of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Overlap Due to Ursodeoxycholic Acid
by: Shatavisa Mukherjee, et al.
Published: (2020)